Soluble Urokinase-Type Plasminogen Activator Receptor Improves Risk Prediction in Patients With Chronic Heart Failure.
暂无分享,去创建一个
J. Wojta | L. Koller | R. Berger | G. Goliasch | M. Hülsmann | S. Stojkovic | A. Niessner | D. Mörtl | B. Richter | P. Sulzgruber | Christos Potolidis | Florian Liebhart | C. Potolidis